Menu
Search
|

Menu

Close
X

Odonate Therapeutics Inc ODT.OQ (NASDAQ Stock Exchange Global Select Market)

15.68 USD
-0.23 (-1.45%)
As of 4:00 PM EDT
chart
Previous Close 15.91
Open 15.84
Volume 12,507
3m Avg Volume 17,935
Today’s High 15.84
Today’s Low 14.94
52 Week High 31.75
52 Week Low 14.94
Shares Outstanding (mil) 26.89
Market Capitalization (mil) 448.28
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
EPS (USD)
FY18
-1.488
FY17
-1.194
FY16
-0.116
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.14
Price to Sales (TTM)
vs sector
--
6.55
Price to Book (MRQ)
vs sector
2.60
4.00
Price to Cash Flow (TTM)
vs sector
--
21.51
Total Debt to Equity (MRQ)
vs sector
0.00
14.15
LT Debt to Equity (MRQ)
vs sector
0.00
11.31
Return on Investment (TTM)
vs sector
--
12.83
Return on Equity (TTM)
vs sector
--
14.95

EXECUTIVE LEADERSHIP

Kevin Tang
Chairman of the Board, Chief Executive Officer, Since 2013
Salary: $1.00
Bonus: --
Jeff Vacirca
Vice Chairman of the Board, Since 2016
Salary: --
Bonus: --
John Lemkey
Chief Financial Officer, Since 2013
Salary: --
Bonus: --
Joseph O'Connell
Chief Medical Officer, Since 2017
Salary: $108,712.00
Bonus: --
Robert Rosen
Director, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

4747 Executive Dr Ste 510
SAN DIEGO   CA   92121-3100

Phone: +1858.2003830

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

SPONSORED STORIES